Our company is seeking seed funding for the development, validation and marketing of our in vitro toxicology screening systems that use human stem cells or 3-D multicellular constructs in tissue culture for target discovery, drug efficacy and safety testing. These systems, combined with artificial and human-assisted intelligence can be used as a platform to discover lead therapeutic candidates and to test compounds for developmental toxicities.